Aisha Jones, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2401 W Belvedere Ave, 103, Baltimore, MD 21215 Phone: 410-601-8165 |
Ms. Linda Dianne Brown, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 51 N Dundalk Ave, Baltimore, MD 21222 Phone: 410-558-7163 Fax: 410-522-6060 |
Keisha L Davis, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4134 E Joppa Rd, Suite 202, Baltimore, MD 21236 Phone: 410-248-9800 |
Ms. Jennifer Ann Perez, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3455 Wilkens Ave Lowr Level20, Baltimore, MD 21229 Phone: 410-627-0876 |
Lisa Malia James, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2225 N Charles St, Baltimore, MD 21218 Phone: 410-366-4360 Fax: 410-243-7948 |
Miss Katoria Precious Osborne, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3455 Wilkens Ave Lowr Level20, Baltimore, MD 21229 Phone: 410-627-0876 |
News Archive
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
What started out as an amendment on the House floor to defund Planned Parenthood has made its way to key battleground states in the 2012 presidential election, with Wisconsin poised to become the fourth state to choke off funding for the women's health provider.
SP PennTech announces the RW-500 rotary vial washer – a small automated system designed for low-to-medium output pharmaceutical and biotech applications.
Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.
› Verified 4 days ago